Home About Our Services Experience Publications News & Events Contact Us Downloads
OUR SERVICES

Health Economics

Patient-Reported Outcomes

Regulatory and Health Outcomes Strategy

Market Access
> Pricing and Reimbursement Strategy
  > Coding, Coverage, and Payment
  > Reimbursement Submissions and Dossiers
> Payer and Physician Research and Engagement
> Health Technology Assessment (HTA) Strategy
> Asset Valuation
> Brand Marketing
  > Strategic plans
  > Product Positioning
  > Launch Plans

Health Preference Assessment

Pharmacoepidemiology and Risk Management

Drug Safety and Pharmacovigilance

Biometrics

Preclinical Pharmaceutical Sciences

Clinical and Medical Services

 

RTI-HS HomeOur ServicesMarket Access › Coding, Coverage, and Payment

Coding, Coverage, and Payment

Our experts can help you navigate through the complex components of coding, coverage, and payment to help you gain reimbursement for your product. We help clients understand the payer’s perspective in determining reimbursement status by thorough assessment of the clinical and economic aspects of your product.

  • The US public and private health care system pays for health services and procedures via descriptive codes used to file claims services rendered.
  • Codes must be adequately descriptive of the service or procedure for legally compliant billing.
  • In the absence of a usable code, a new service, procedure. or technology must pursue a new code or use an unlisted code.
  • US public and private payers may cover services, procedures. or technologies deemed medically necessary. New technologies that meet medical necessary criteria may still face noncoverage if they are viewed as investigational/experimental.
  • Payers may limit market access and utilization by limiting coverage as follows:
    • By site of care (inpatient vs. outpatient)
    • To specific facilities (e.g., Centers of Excellence)
    • To specific patient subpopulations
    • By employing payer utilization management controls (e.g., prior authorization, step therapy, formulary placement)
  • US public and private payment systems vary by site of care (e.g., inpatient, outpatient, physician office).
  • Payment for services, procedures, and technologies may be bundled (i.e., all costs, including technologies, are paid in a single predetermined payment) or can be eligible for payment as separate component procedures/procedural steps.
  • New technology utilization may be challenged by providers if use under bundled payment schedules diminishes the provider’s margin for rendering the procedure.

Obstacles in any one area can limit or preclude market access and ability to obtain sufficient payment.

 


 
SENIOR LEADERSHIP

 
Kati Copley-Merriman, MS, MBA
Vice President, Regulatory and Health Outcomes Strategy and Market Access
A Brett Hauber, PhD
Global Head of Health Preference Assessment and Market Access
Stephen M Beard, MSc
Global Head of Health Economics, Europe
Stephanie R Earnshaw, PhD
Vice President, US Health Economics
Eric Faulkner, MPH
Senior Director, Pricing and Reimbursement, Market Access
Barbara Rivera, MBA
Director of Commercial Services
Allan Scott, MHA
Director, Market Access
Deirdre Mladsi, BA
Head, Health Economics and Market Access
Salome de Cambra, MD
Senior Consultant, European Pricing and Reimbursement

For a full list of scientific staff bios, click here.


 
DOWNLOADS

 

CONTACT US
To learn more about our research and consulting services, please call us at:
US: +1.800.262.3011
Spain: +34.93.241.7766
UK: +44(0)161.232.3400
Or email one of our experts directly.
Home | About | Our Services | Experience | Publications | News & Events | Contact Us | Downloads
©2008 RTI Health Solutions. All Rights Reserved.